Stem Cell Differentiation via Transcription Factor Engineering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating hepatocytes or hepatic cells from pluripotent stem cells (PSCs) are inefficient and require complex differentiation protocols, often involving multiple steps and varying media conditions.

Innovation Solution

Engineering PSCs to express a specific nucleic acid encoding a combination of hepatocyte nuclear factor (HNF) family members, forkhead box (FOX) family members, and additional transcription factors, such as FOS, JUN, and GATA, to induce direct differentiation into hepatocytes or hepatic cells within 30 days or less.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If complex differentiation protocols with multiple steps and varying media conditions are used, then hepatocyte generation is achieved, but the process is inefficient and time-consuming

Engineering Contradiction:
Improvehepatocyte generation efficiencyVSAvoiddifferentiation protocol complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent introduces transcription factor genes (HNF4A, HNF1A, ONECUT1, FOXA1, CEBPA, RBPJ) into pluripotent stem cells before differentiation begins. This preliminary genetic modification pre-programs the cells with hepatocyte-specific transcription factors, allowing them to differentiate more rapidly and efficiently without requiring complex multi-step protocols with varying media conditions.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the biological parameter of transcription factor expression by introducing specific genes (HNF4A, HNF1A, ONECUT1, FOXA1, CEBPA, RBPJ) into the PSCs. This genetic parameter change enables the cells to undergo direct differentiation into hepatocytes within 30 days or less, dramatically improving productivity while simplifying the differentiation protocol.

Inventive Principle:
Principle #35Parameter changes

2Loss of time

If traditional differentiation methods are used, then hepatocytes are generated, but extensive media modifications and prolonged differentiation times are required

Engineering Contradiction:
Improvedifferentiation timeVSAvoidmedia modification complexity
Core Design Contradiction:
Loss of timeVSEase of manufacture

Solution Approach 1:

By pre-introducing hepatocyte-specific transcription factor genes into PSCs, the differentiation process is accelerated. The cells are pre-programmed with the necessary genetic machinery to become hepatocytes, eliminating the need for extensive media modifications and reducing differentiation time to 30 days or less.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts the essential differentiating factors (transcription factors HNF4A, HNF1A, ONECUT1, FOXA1, CEBPA, RBPJ) and introduces them directly into PSCs via genetic modification. This removes the need for complex external media conditions and prolonged culture periods, achieving rapid hepatocyte generation with simplified procedures.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the rapid and efficient generation of populations of hepatocytes or hepatic cells that express markers like ASGR-1 and CXCR-4, with high purity and functionality, without the need for extensive media modifications or prolonged differentiation times.

Implementation Method 1

Stem cells can be programmed into various phenotypes via the introduction of one or more transcription factors, or one or more molecules that modulate transcription or transcription factors.

Methodology Applied
Scientific EffectTranscription factor binding:

Data Source

PatentUS20250188419A1Methods and compositions for stem cell differentiation
Publication Date: 2025.06.12 GC THERAPEUTICS INC
  • US20250188419A1 patent drawing
  • US20250188419A1 patent drawing
  • US20250188419A1 patent drawing

AI summary

The present disclosure provides transcription factors and methods for stem cell differentiation into hepatocytes or hepatic cells. In some examples, a pluripotent stem cell (PSC) comprises a nucleic acid. In some examples, the nucleic acid comprises an open reading frame encoding one or more transcription factors, one or more transcription factors, or an activator of transcription of the open reading frame encoding one or more transcription factors. In some examples, the nucleic acid comprising an open reading frame encoding one or more transcription factors, the one or more transcription factors, or the activator of transcription of the open reading frame encoding one or more transcription factors induces differentiation of the PSC into a hepatocyte or a hepatic cell.